Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Current Deferred Revenue (2020 - 2025)

NeuroPace has reported Current Deferred Revenue over the past 4 years, most recently at $141000.0 for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $141000.0 for Q4 2025, down 76.5% from a year ago — trailing twelve months through Dec 2025 was $141000.0 (down 76.5% YoY), and the annual figure for FY2025 was $141000.0, down 76.5%.
  • Current Deferred Revenue for Q4 2025 was $141000.0 at NeuroPace, down from $600000.0 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for NPCE hit a ceiling of $1.1 million in Q4 2023 and a floor of $141000.0 in Q4 2025.
  • Median Current Deferred Revenue over the past 3 years was $700000.0 (2025), compared with a mean of $694333.3.
  • Peak annual rise in Current Deferred Revenue hit 12.5% in 2025, while the deepest fall reached 76.5% in 2025.
  • NeuroPace's Current Deferred Revenue stood at $1.1 million in 2023, then plummeted by 44.95% to $600000.0 in 2024, then plummeted by 76.5% to $141000.0 in 2025.
  • The last three reported values for Current Deferred Revenue were $141000.0 (Q4 2025), $600000.0 (Q3 2025), and $700000.0 (Q2 2025) per Business Quant data.